Mark C BlaserDaniel ReichartAbhijeet SonawaneFlorian SchlotterArda HaluLivia Silva A PassosDaniel DeLaughterWunan ZhouRon BlanksteinMARCELO DI CARLIMaria D NunesTsuyoshi Kanekosimon robsonSimon C BodyJ Daniel D MuehlschlegelChristine E SeidmanJonathan G SeidmanMasanori AikawaSasha A SinghElena AikawaBrigham and Women's Hosp,Boston,MAHarvard Med Sch,Boston,MANational Institutes of Health,Bethesda,MDUFMG,Belo Horizonte,BrazilBeth Israel Deaconess Med Cntr,Boston,MABoston Univ Sch Medicine,Boston,MA

Abstract:Circulation, Volume 146, Issue Suppl_1, Page A12839-A12839, November 8, 2022. Introduction:Bicuspid aortic valve (BAV) is the most common congenital cardiac defect, occurring in 1.5% of humans. Due to unknown pathogenic mechanisms, over 70% of those with BAV develop calcific aortic valve disease (CAVD). These patients require valve replacement 25x more frequently and a decade earlier than those with a tricuspid aortic valve (TAV).Objective:Identify cellular and molecular drivers of accelerated disease in BAV-CAVD.Methods:Small RNA-seq, RNA-seq, and proteomics were performed on 70 human aortic valves (11 non-diseased TAVs; fibrotic and calcific stages of 32 TAVs and 27 BAVs excised for CAVD). Single nuclei RNA-seq (snRNA-seq) was completed on 54,608 nuclei from 13 additional human valves (4 non-diseased TAVs; 5 TAVs and 4 BAVs with CAVD).Results:4,938 miRs, transcripts, and proteins were differentially enriched between stages of BAV- and TAV-CAVD (q<0.05). Multi-omics data, CT-derived valve calcification, and 29 clinical parameters were integrated by latent factor analysis. Protein-protein interaction networks revealed significantly elevated adaptive immune responses in BAV-CAVD: T cell/B cell inflammatory activation was enhanced and SLIT-ROBO signaling disrupted in diseased BAVs. snRNA-seq identified 10 major cell types in human aortic valves: valvular interstitial cells (65% of cells; 3 states), endothelial cells (10%; 2), macrophages (13%), T cells (8%; 2), and B cells (3%; 2). CAVD drove differentiation of dual side-specific endothelial subpopulations, enrichment of CARMN/CACNA1C/ACTA2-high interstitial cells, and substantial immune cell accumulation. B cells were further enriched in BAV- vs. TAV-CAVD.Conclusions:Adaptive immunity underpins molecular differences in BAV- vs. TAV-CAVD and is a novel avenue for tailored pharmacotherapy. We potentiate targeting of key cellular subpopulations by defining the dissociation bias-free transcriptional and cellular diversity of human CAVD at single-cell resolution.

Filamin A heart valve disease as a genetic cause of inherited bicuspid and tricuspid aortic valve disease

Exon 47 Skipping of Fibrillin-1 Leads Preferentially to Cardiovascular Defects in Patients with Thoracic Aortic Aneurysms and Dissections

Bilateral Periventricular Nodular Heterotopia Caused By A Novel Splicing Mutation In The Flna Gene In A Chinese Family

Sinus of Valsalva Aneurysm in Females

Variable clinical expression of a novel FLNC truncating variant in a large family

Elucidation of the genetic causes of bicuspid aortic valve disease

A mutation update for the FLNC gene in myopathies and cardiomyopathies

Tools to differentiate between Filamin C and Titin truncating variant carriers: value of MRI

Where the congenital heart disease meets the pulmonary arterial hypertension, FLNA matters: a case report and literature review

Pathogenic FLNA variants affecting the hinge region of filamin A are associated with male survival

A distinct X-linked syndrome involving joint contractures, keloids, large optic cup-to-disc ratio, and renal stones results from a filamin A (FLNA) mutation

Targeted Next-Generation Sequencing Identified ADAMTS5 As Novel Genetic Substrate in Patients with Bicuspid Aortic Valve.

Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias

Multicenter Clinical and Functional Evidence Reclassifies a Recurrent Non-canonical Filamin C Splice-altering Variant

Acute Stanford type B aortic dissection—who benefits from genetic testing?

The Fbn1 gene variant governs passive ascending aortic mechanics in the mgΔlpn mouse model of Marfan syndrome when superimposed to perlecan haploinsufficiency

Significance of Fibrillin-1, Filamin A, MMP2 and SOX9 in Mitral Valve Pathology

Abstract 12839: Integrated Multi-Omics and Single Nucleus Transcriptomics Highlight Enhanced Adaptive Immune Responses in Human Bicuspid Aortic Valve Stenosis

The FLNC Ala1186Val Variant Linked to Cytoplasmic Body Myopathy and Cardiomyopathy Causes Protein Instability

Increased Frequency of FBN1 Frameshift and Nonsense Mutations in Marfan Syndrome Patients with Aortic Dissection

Fibrillin-1 (FBN1) Mutations in Patients With Thoracic Aortic Aneurysms